Invesco’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.8K Sell
68,340
-4,042
-6% -$5.88K ﹤0.01% 3746
2026
Q1
$105K Buy
72,382
+13,442
+23% +$21.3K ﹤0.01% 3616
2025
Q4
$81.3K Buy
58,940
+26,194
+80% +$54.8K ﹤0.01% 3657
2025
Q3
$89.4K Buy
32,746
+4,134
+14% +$14.7K ﹤0.01% 3695
2025
Q2
$99.9K Buy
+28,612
New +$113K ﹤0.01% 3650
2021
Q4
Sell
-13,510
Closed -$89K 4099
2021
Q3
$89K Sell
13,510
-216,873
-94% -$2.08M ﹤0.01% 3955
2021
Q2
$3.69M Buy
+230,383
New +$3.18M ﹤0.01% 2581

Other funds holding STIM

Invesco's STIM Position: Q2 2026 in Review

Invesco reduced its Neuronetics (STIM) stake by 5.6% in Q2 2026, selling an estimated $5.88K and leaving 68,340 shares worth $88.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

Invesco first reported a position in STIM in Q2 2021 and has held it in 7 quarters since. The position peaked at $3.69M in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Invesco held 68,340 shares of Neuronetics worth $88.8K as of Q2 2026.
  • Invesco sold 4,042 Neuronetics shares in Q2 2026, an estimated $5.88K.
  • Neuronetics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3746 holding.
  • Invesco first reported a position in Neuronetics in Q2 2021 and has held it in 7 quarters since.
  • Invesco's Neuronetics position peaked at $3.69M in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.